MAXHEALTH.NSMAXHEALTH.NSNSE
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+24.6%
5Y CAGR+83.8%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+24.6%/yr
vs +69.0%/yr prior
5Y CAGR
+83.8%/yr
Recent deceleration
Acceleration
-44.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
21x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$18.31B+23.6%
2024$14.82B+21.2%
2023$12.23B+29.2%
2022$9.47B+143.0%
2021$3.90B+345.8%
2020$873.90M-42.6%
2019$1.52B+31.3%
2018$1.16B-17.8%
2017$1.41B+44.1%
2016$979.40M-